Aleafia Health Inc ALEAF

Healthcare Cannabis

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.

GREY:ALEAF - Post by User

Aleafia Health Inc > So...

<< Previous

Bullboard Posts

Next >>

Comment by Francoicon Feb 24, 2021 4:24pm

186 Views

Post# 32650242

RE:RE:RE:RE:RE:RE:RE:RE:RE:So...

It is time to announce the release date of the results for the 4th quarter and for the year 2020. A bit of information reported excellent results would not hurt either.

Toweringmars wrote:

Building on record cannabis net revenue realized in the quarter ended December 31, 2020 (“ Q4 2020 ”), the Company is pleased to report on additional near term growth opportunities across the medical, adult-use, and international sales channels.

Q1 - 2020 = $13.7M cannabis net revenue, 183% increase over previous quarter, and 2,486% increase over prior year’s quarter.

We know definatively that Q4 2020 will be 'better' than 13.7m.

stocktracker101 wrote: On the q3 earnings release they guided about $16 million wholesale flower sales.
They also guided that a portion of those sales could spill over into q1..
Im not sure what rec / medical sales are for q4. I am thinking we will see more of that in q1 than q4.
High end $16 million +, Low end $10 - $12 million.

anmckenn wrote: stocktracker 101, what is the estimates for revenue for this coming announcment on Mar 19?

Building on record cannabis net revenue realized in the quarter ended December 31, 2020 (“ Q4 2020 ”), the Company is pleased to report on additional near term growth opportunities across the medical, adult-use, and international sales channels.